Items
Contributor is exactly
Rachel Jiang
-
2020-05-22
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
The new process of coronavirus vaccine in China -
2020-05-25
An optional final due to Coronavirus concern of email from professor
Due to coronavirus, many people lost their job and concern about their lives. Professor sent us this email to help us to get out of the trouble of coronavirus that she gives us a chance to take optional final.